Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2006 3
2007 3
2008 5
2009 1
2011 5
2012 13
2013 14
2014 9
2015 6
2016 3
2017 7
2018 10
2019 16
2020 35
2021 39
2022 23
2023 15
2024 16

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

179 results

Results by year

Filters applied: . Clear all
Page 1
Segmentectomy for ground-glass-dominant lung cancer with a tumour diameter of 3 cm or less including ground-glass opacity (JCOG1211): a multicentre, single-arm, confirmatory, phase 3 trial.
Aokage K, Suzuki K, Saji H, Wakabayashi M, Kataoka T, Sekino Y, Fukuda H, Endo M, Hattori A, Mimae T, Miyoshi T, Isaka M, Yoshioka H, Nakajima R, Nakagawa K, Okami J, Ito H, Kuroda H, Tsuboi M, Okumura N, Takahama M, Ohde Y, Aoki T, Tsutani Y, Okada M, Watanabe SI; Japan Clinical Oncology Group. Aokage K, et al. Among authors: tsutani y. Lancet Respir Med. 2023 Jun;11(6):540-549. doi: 10.1016/S2213-2600(23)00041-3. Epub 2023 Mar 6. Lancet Respir Med. 2023. PMID: 36893780 Clinical Trial.
Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer with radiologically pure-solid appearance in Japan (JCOG0802/WJOG4607L): a post-hoc supplemental analysis of a multicentre, open-label, phase 3 trial.
Hattori A, Suzuki K, Takamochi K, Wakabayashi M, Sekino Y, Tsutani Y, Nakajima R, Aokage K, Saji H, Tsuboi M, Okada M, Asamura H, Nakamura K, Fukuda H, Watanabe SI; Japan Clinical Oncology Group; West Japan Oncology Group. Hattori A, et al. Among authors: tsutani y. Lancet Respir Med. 2024 Feb;12(2):105-116. doi: 10.1016/S2213-2600(23)00382-X. Epub 2024 Jan 3. Lancet Respir Med. 2024. PMID: 38184010 Clinical Trial.
Bronchoplasties at the Segmental Level.
Tsutani Y, Okada M. Tsutani Y, et al. Thorac Surg Clin. 2018 Aug;28(3):299-304. doi: 10.1016/j.thorsurg.2018.04.002. Thorac Surg Clin. 2018. PMID: 30054067 Review.
Reply to Zhou et al.
Kagimoto A, Tsutani Y, Okada M. Kagimoto A, et al. Among authors: tsutani y. Eur J Cardiothorac Surg. 2022 Sep 2;62(4):ezac245. doi: 10.1093/ejcts/ezac245. Eur J Cardiothorac Surg. 2022. PMID: 35396984 No abstract available.
Reply to Zhou and Yu.
Ueda D, Tsutani Y, Okada M. Ueda D, et al. Among authors: tsutani y. Eur J Cardiothorac Surg. 2023 Jun 1;63(6):ezad195. doi: 10.1093/ejcts/ezad195. Eur J Cardiothorac Surg. 2023. PMID: 37228037 No abstract available.
Reply to Sanz-Santos et al.
Kawamoto N, Tsutani Y, Okada M. Kawamoto N, et al. Among authors: tsutani y. Eur J Cardiothorac Surg. 2023 Mar 1;63(3):ezad084. doi: 10.1093/ejcts/ezad084. Eur J Cardiothorac Surg. 2023. PMID: 36883693 No abstract available.
Reply to Zhang et al.
Kamigaichi A, Tsutani Y, Okada M. Kamigaichi A, et al. Among authors: tsutani y. Eur J Cardiothorac Surg. 2021 Apr 29;59(4):928. doi: 10.1093/ejcts/ezaa419. Eur J Cardiothorac Surg. 2021. PMID: 33346347 No abstract available.
179 results